Neuropeptide Y‐enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
- 1 September 1996
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 495 (2) , 525-534
- https://doi.org/10.1113/jphysiol.1996.sp021612
Abstract
1. Neuropeptide Y (NPY) has been reported to enhance diuresis and natriuresis in anaesthetized rats although it is a potent renal vasoconstrictor in vitro in vivo in several species. Therefore, we have investigated anaesthetized rats to see whether reduction in renal blood flow (RBF) and enhancement of diuresis and natriuresis can occur concomitantly, and how diuresis and natriuresis might be enhanced despite reduced RBF. 2. Systemic or intrarenal NPY infusion (0.03‐3 micrograms kg‐1 min‐1) had only a small effect on mean arterial pressure (maximal increase 15‐20 mmHg) and heart rate (maximal decrease 30 beats min‐1) but dose‐dependently reduced RBF (maximal peak reduction 3 ml min‐1) Endogenous creatinine clearance was not significantly altered. 3. In anaesthetized rats systemic infusion of 1 or 3 micrograms kg‐1 min‐1 NPY enhanced urine formation and sodium and calcium excretion by a maximum of 110, 110 and 45%, respectively, but did not alter potassium excretion. Enhancement of diuresis was also detectable in conscious rats. 4. The diuretic and natriuretic effects of systemically infused NPY were at least partly maintained in rats with decapsulated kidneys and in rats where NPY‐induced increase of renal perfusion pressure was excluded mechanically by an adjustable clamp placed on the abdominal aorta. 5. Intrarenal infusion of 0.3 or 1 microgram kg‐1 min‐1 NPY reduced RBF to a greater extent than systemic infusion (maximal peak reduction 4 ml min‐1) but caused a smaller enhancement or even a reduction of urine formation and sodium excretion. 6. We conclude that systemic infusion of NPY reduces RBF by a direct effect on the renal vasculature. Systemic NPY infusion enhances urine formation and sodium and calcium excretion. This occurs independently (at least in part) of pressure natriuresis by formation and/or release of an extrarenal factor which might act on distal tubules and/or collecting ducts.Keywords
This publication has 18 references indexed in Scilit:
- Rapid desensitization of adrenaline‐ and neuropeptide Y‐stimulated Ca2+ mobilization in HEL‐cellsBritish Journal of Pharmacology, 1994
- The mechanism of pressure natriuresisJournal Of Hypertension, 1990
- Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha2, NPY and angiotensin II receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- Release and vasoconstrictor effects of neuropeptide Y in relation to non‐adrenergic sympathetic control of renal blood flow in the pigActa Physiologica Scandinavica, 1989
- Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbitJournal of the Autonomic Nervous System, 1989
- Identification of noradrenergic nerve terminals immunoreactive for neuropeptide Y and vasoactive intestinal peptide in the rat kidneyJournal of Anatomy, 1989
- Disparate effects of neuropeptide Y and clonidine on the excretion of sodium and water in the ratEuropean Journal of Pharmacology, 1988
- Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandin systems. State of the art lecture.Hypertension, 1988
- Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activityClinical Science, 1985
- The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPYHistochemistry and Cell Biology, 1984